Humanized Mouse and Rat Model Market, By Type (Humanized Mouse Models (Genetic Humanized Mouse Models and Cell-Based Humanized Mouse Models (Cd34 Humanized Mouse Models, PBMC Humanized Mouse Models and BLT Humanized Mouse Models) and Humanized Rat Model), By Application (Oncology, Immunology and Infectious Diseases, Neuroscience, Toxicology, Hematopoiesis and, Other Applications), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic & Research Institutions), and By Region (North America, Europe, Asia Pacific, Latin America, And Middle East & Africa) - Trends, Analysis And Forecast Till 2034

Report Code: PMI391520 | Publish Date: April 2024 | No. of Pages: 180

Global Humanized Mouse And Rat Overview

Introduction:

Humanized Mouse and Rat Model Market accounted for US$ 252 Billion in 2024 and is estimated to be US$ 466.8 Billion by 2034 and is anticipated to register a CAGR of 6.40%.

The humanized mouse and rat model are most commonly used as small animal models in medical and biological research for human therapeutics. A humanized immune system rodent model is one in which human primary hematopoietic cells and tissues are implanted into the immunodeficient host which generates the functional human immune system. It possesses functioning human genes, cells, tissues, and/or organs in case of biological and medical research. These mouse models are used to model the human immune system in scenarios of health and pathology. Mouse models are used for identification of immunodeficiency disorders, cancers, and other rare diseases.

Global Humanized Mouse And Rat Dynamics

Increase in R&D activities carried out by pharmaceutical & biotechnology companies, continuous support & initiatives from governments & private sectors for research on mouse models coupled with growth in adoption of modified medicine has increased the demand for personalized mouse models.  Humanized mouse models will bring in healthy gains adding significant momentum to the global growth. Increased production of monoclonal antibodies and improvement of healthcare in developing nations are expected to provide a wide range of growth opportunities for players in the target market.  Moreover, at every medical sector it become prime stuff to be work on regarding research because of its high potential application and will shape growth and development of market in emerging countries. However, stringent regulations and laws formulated for ethical use of animals and costly procedures for maintenance of animal housing restrain the growth of the global humanized mouse model market.

Global Humanized Mouse And Rat Segmentation

Humanized mouse and rat model market is segmented based on type, application, end user and region.

Based on type, the global humanized mouse and rat model market is segmented into humanized mouse models and humanized rat models. Humanized mouse models is subdivided into genetic humanized mouse models and cell-based humanized mouse models. Cell-based humanized mouse models is subdivided into cd34 humanized mouse models, PBMC humanized mouse models and BLT humanized mouse models. Based on the application, the global market is segmented into oncology, immunology and infectious diseases, neuroscience, toxicology, hematopoiesis and other applications. Based on end user, the global market is segmented into pharmaceutical & biotechnology companies, contract research organizations and academic & research institutions.

Based on the region the global humanized mouse and rat model market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the global humanized mouse and rat model market due to increasing geriatric population. Asia pacific humanized mouse and rat model market is projected to register a high CAGR over the forecast period owing to the increasing trend increasing number of R&D activities in pharmaceutical and biotechnology companies, and continuous support in the form of investments and grants from the government and private sectors are expected to provide a wide range of growth opportunities for players in the market.

Humanized Mouse & Rat Model Market, By Type:

  • Humanized Mouse Models
    • Genetic Humanized Mouse Models
    • Cell-Based Humanized Mouse Models
      • Cd34 Humanized Mouse Models
      • PBMC Humanized Mouse Models
      • BLT Humanized Mouse Models
  • Humanized Rat Models

Humanized Mouse & Rat Model Market, By Application:

  • Oncology
  • Immunology And Infectious Diseases
  • Neuroscience
  • Toxicology
  • Hematopoiesis
  • Other Applications

Humanized Mouse & Rat Model Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic & Research Institutions

Humanized Mouse & Rat Model Market, By Region:

  • North America
    • Middle East & Africa
      • Middle East & Africa Humanized Mouse & Rat Model Market, By Type
      • Middle East & Africa Humanized Mouse & Rat Model Market, By Application
      • Middle East & Africa Humanized Mouse & Rat Model Market, By End User
      • Middle East & Africa Humanized Mouse & Rat Model Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest Of Middle East & Africa
    • Latin America
      • Latin America Humanized Mouse & Rat Model Market, By Type
      • Latin America Humanized Mouse & Rat Model Market, By Application
      • Latin America Humanized Mouse & Rat Model Market, By End User
      • Latin America Humanized Mouse & Rat Model Market, By Country
        • Brazil
        • Mexico
        • Rest Of Latin America
    • Asia Pacific
      • Asia Pacific Humanized Mouse & Rat Model Market, By Type
      • Asia Pacific Humanized Mouse & Rat Model Market, By Application
      • Asia Pacific Humanized Mouse & Rat Model Market, By End User
      • Asia Pacific Humanized Mouse & Rat Model Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest Of Asia Pacific
    • Europe
      • Europe Humanized Mouse & Rat Model Market, By Type
      • Europe Humanized Mouse & Rat Model Market, By Application
      • Europe Humanized Mouse & Rat Model Market, By End User
      • Europe Humanized Mouse & Rat Model Market, By Country
        • Germany
        • U.K
        • France
        • Russia
        • Italy
        • Rest Of Europe
    • North America Humanized Mouse & Rat Model Market, By Type
    • North America Humanized Mouse & Rat Model Market, By Application
    • North America Humanized Mouse & Rat Model Market, By End User
    • North America Humanized Mouse & Rat Model Market, By Country
      • U.S.
      • Canada

Global Humanized Mouse And Rat Key Players

The key players operating the humanized mouse and rat model market involves Vitalstar Biotechnology, The Jackson Laboratory, Taconic Biosciences, Ingenious Targeting Laboratory, Horizon Discovery (Sage Labs), Hera Biolabs, Genoway, Crown Bioscience (Subsidiary Of Jsr Corporation), Champions Oncology, And Axeni.  Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market.

Global Humanized Mouse And Rat Company Profile

  • Vitalstar Biotechnology
    • Company Overview
    • Product Portfolio\
    • Key Highlights
    • Financial Performance
  • The Jackson Laboratory
  • Taconic Biosciences
  • Ingenious Targeting Laboratory
  • Horizon Discovery (Sage Labs)
  • Hera Biolabs
  • Genoway
  • Crown Bioscience (Subsidiary Of Jsr Corporation)
  • Champions Oncology
  • Axenis

 “*” marked represents similar segmentation in other categories in the respective section.

Global Humanized Mouse And Rat Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Industry Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Humanized Mouse and Rat Model Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Humanized Mouse Models
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
        • Genetic Humanized Mouse Models
        • Cell-Based Humanized Mouse Models
          1. CD34 Humanized Mouse Models
          2. PBMC Humanized Mouse Models
          3. BLT Humanized Mouse Models
    • Humanized Rat Models
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Market Segmentation, By Application, 2020-2030,(US$Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Oncology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Immunology and Infectious Diseases
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Neuroscience
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Toxicology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Hematopoiesis
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Applications
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Market Segmentation, By End User, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Pharmaceutical  and Biotechnological Companies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Contract Research Organization
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Academic and Research Institutes
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Products, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
    • Vitalstar Biotechnology
      • Financial Overview
      • Key Highlights
      • Product Portfolio
      • Company Overview
      • The Jackson Laboratory
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Taconic Biosciences
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Ingenious Targeting Laboratory
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Horizon Discovery
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Hera Biolabs
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Genoway
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Crowns Biosciences
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Champions Oncology
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Axenis
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
  11. The Last Word
    • Future Impact
    • About Us
    • Contact